178 related articles for article (PubMed ID: 19452083)
1. [Recombinant erythropoietin as treatment for hyporegenerative anemia following hemolytic disease of the newborn].
Donato H; Bacciedoni V; García C; Schvartzman G; Vain N
Arch Argent Pediatr; 2009 Apr; 107(2):119-25. PubMed ID: 19452083
[TBL] [Abstract][Full Text] [Related]
2. Late hyporegenerative anemia in neonates with rhesus hemolytic disease.
al-Alaiyan S; al Omran A
J Perinat Med; 1999; 27(2):112-5. PubMed ID: 10379500
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human erythropoietin in the prevention of late anemia in intrauterine transfused neonates with Rh-isoimmunization.
Zuppa AA; Alighieri G; Calabrese V; Visintini F; Cota F; Carducci C; Antichi E; Noia GA; Fortunato G; Romagnoli C
J Pediatr Hematol Oncol; 2010 Apr; 32(3):e95-101. PubMed ID: 20216236
[TBL] [Abstract][Full Text] [Related]
4. Use of recombinant erythropoietin for the management of severe hemolytic disease of the newborn of a K0 phenotype mother.
Manoura A; Korakaki E; Hatzidaki E; Saitakis E; Maraka S; Papamastoraki I; Matalliotakis E; Foundouli K; Giannakopoulou C
Pediatr Hematol Oncol; 2007; 24(1):69-73. PubMed ID: 17130116
[TBL] [Abstract][Full Text] [Related]
5. Recombinant erythropoietin as treatment for the late hyporegenerative anemia of Rh hemolytic disease.
Ohls RK; Wirkus PE; Christensen RD
Pediatrics; 1992 Nov; 90(5):678-80. PubMed ID: 1408538
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin as treatment for late hyporegenerative anemia in neonates with Rh hemolytic disease after in utero exchange transfusion.
Nicaise C; Gire C; Casha P; d'Ercole C; Chau C; Palix C
Fetal Diagn Ther; 2002; 17(1):22-4. PubMed ID: 11803211
[TBL] [Abstract][Full Text] [Related]
7. Management of late anemia in Rhesus hemolytic disease: use of recombinant human erythropoietin (a pilot study).
Ovali F; Samanci N; Dağoğlu T
Pediatr Res; 1996 May; 39(5):831-4. PubMed ID: 8726237
[TBL] [Abstract][Full Text] [Related]
8. Prolonged anemia in an intrauterine-transfused neonate with Rh-hemolytic disease: no evidence for anti-D-related suppression of erythropoiesis in vitro.
Dorn I; Schlenke P; Härtel C
Transfusion; 2010 May; 50(5):1064-70. PubMed ID: 20003047
[TBL] [Abstract][Full Text] [Related]
9. An unusual case of ABO-haemolytic disease of the newborn.
Haque KM; Rahman M
Bangladesh Med Res Counc Bull; 2000 Aug; 26(2):61-4. PubMed ID: 11508073
[TBL] [Abstract][Full Text] [Related]
10. Recombinant erythropoietin in the prevention of late anaemia in intrauterine transfused neonates with Rh-haemolytic disease.
Zuppa AA; Maragliano G; Scapillati ME; Florio MG; Girlando P; Noia G; De Santis M; Cavaliere AF; Romagnoli C; Tortorolo G
Fetal Diagn Ther; 1999; 14(5):270-4. PubMed ID: 10529568
[TBL] [Abstract][Full Text] [Related]
11. Is there a role for erythropoietin in neonatal medicine?
Mainie P
Early Hum Dev; 2008 Aug; 84(8):525-32. PubMed ID: 18653293
[TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn.
Nasseri F; Mamouri GA; Babaei H
Saudi Med J; 2006 Dec; 27(12):1827-30. PubMed ID: 17143357
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human erythropoietin and blood transfusion in low-birth weight preterm infants under restrictive transfusion guidelines.
Badiee Z; Pourmirzaiee MA; Kelishadi R; Naseri F
Saudi Med J; 2006 Jun; 27(6):817-20. PubMed ID: 16758042
[TBL] [Abstract][Full Text] [Related]
14. [Human recombinant erythropoietin therapy].
Donato H; Ferro H
Medicina (B Aires); 2006; 66(1):51-69. PubMed ID: 16555732
[TBL] [Abstract][Full Text] [Related]
15. Alternatives to blood product transfusion in the critically ill: erythropoietin.
Stubbs JR
Crit Care Med; 2006 May; 34(5 Suppl):S160-9. PubMed ID: 16617261
[TBL] [Abstract][Full Text] [Related]
16. Correlation of Fc(gamma)RIIa (CD32) Polymorphism and IgG Antibody Subclasses in Hemolytic Disease of Newborn.
Wu Q; Zhang Y; Liu M; Wang B; Liu S; He C
Neonatology; 2009; 96(1):1-5. PubMed ID: 19129718
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of neonatal rhesus hemolytic anemia with high doses of recombinant human erythropoietin.
Wacker P; Ozsahin H; Stelling MJ; Humbert J
Pediatr Hematol Oncol; 2001 Jun; 18(4):279-82. PubMed ID: 11400653
[TBL] [Abstract][Full Text] [Related]
18. Hyporegenerative anemia associated with intrauterine transfusion in rhesus hemolytic disease.
Thorp JA; O'Connor T; Callenbach J; Cohen GR; Yeast JD; Albin J; Plapp F
Am J Obstet Gynecol; 1991 Jul; 165(1):79-81. PubMed ID: 1853921
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
[TBL] [Abstract][Full Text] [Related]
20. [Hemolytic disease of neonates due to anti-M: report of one case and review of reports of 21 cases].
Gao XY; Huang H; Li LD
Zhonghua Er Ke Za Zhi; 2009 Sep; 47(9):648-52. PubMed ID: 20021783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
